Delve into the 2023 Cancer Vaccine Landscape

A comprehensive analysis of the drugs, trials, deals, and companies’ landscapes for the Cancer Vaccine space and regulatory announcements from 2023.

Download Here

About the 2023 Landscape Review

The cancer vaccine space is predominantly clinical, with 58% of assets either being currently clinically active, or having been clinically active at some point in their development. Among all the therapeutic classes of cancer vaccines, viral vaccines are the fastest, followed closely by nucleic acid-based vaccines. As of January 2024, 24 trials are expected to begin, and 145 trials are anticipated to end.

Nucleic acid-based vaccines were the second-fastest-growing therapeutic class in the cancer vaccine sector in 2023, accounting for 36% of new drugs. Our latest data expansion has added exclusive deals and companies’ insights, providing an unrivaled understanding of the commercial market and the future of the space.

If you want to get these details and more, you can download the 2023 Cancer Vaccine Landscape report.

You may also be interested in...

Investment Trends in Early-Stage Biopharma: A Beacon Data Perspective

Find out more

Beacon Cancer Vaccine: 2024 ASCO Annual Meeting Abstracts

Find out more

The 2023 TPD Landscape Review

Find out more

2023 Oncolytic Viruses Landscape Review

Find out more

2023 Cancer Vaccine Landscape Review

Find out more

Infographic 2023 Cancer Vaccine ESMO Abstracts Analysis

Find out more

Find out more

Beacon is the essential decision-support tool for developers of complex therapeutics. Our market-defining, proprietary ontologies combined with the most accurate and comprehensive life sciences data, provide our customers with unparalleled visibility of the drug, trial and commercial landscape.

Each dataset features proprietary, hyper-relevant search and filtering tailored to specific modalities, in-depth data, plus additional market insight curated by our subject matter experts. Beacon is here to support you in making these decisions with confidence through our encompassing database solution.

With Beacon, you can make drug development decisions with confidence. This is why 23 out of the world’s top 25 drug developers trust us.


Discover a database tailored to your needs

Speak with our team

Our dedicated account and research teams can help you with questions by showing you how this insight and data is collated on Beacon.


Get Started